NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/24/2022
Back to search
Official data from USPTO
PHARMACEUTICAL STRATEGIES GROUP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMACEUTICAL STRATEGIES GROUP
ST13
US500000085643199Class
35
Filing
85643199
Registration
4242118
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
03/24/2022
Trademark type
Word
Nice classes
35
Filing date
06/05/2012
Registration date
11/13/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2022
Last transaction
03/24/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2003-00-00
First use in commerce
2003-00-00
Drawing code
4
Owner type
16
Owner location
Plano, TX, US
Examiner
FRENCH, CURTIS
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Pharmaceutical Strategies Group, LLC
Representatives
Camille M. Miller Cozen O'Connor
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting services; Business management consulting; Business organization consulting; Pharmacy benefit consulting for health and pharmacy benefit plan sponsors; Analyzing and compiling data for measuring the performance of pharmacies and pharmacy programs; Auditing of pharmacy benefit claims data; Business auditing; Forensic accounting services; Negotiations of contracts for pharmacy benefit programs; Business consulting servicesassisting with development and scoring of request for proposals; Management of pharmaceutical drug programs for health care facilitiesemployerslabor unionshealth planspharmaceutical cost management
Publications
History of USPTO decisions and trademark events.
39 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/24/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/24/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/24/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
11/16/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/13/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/21/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/21/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/21/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/21/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/21/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/21/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/04/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/04/2018
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/12/2018
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
12/08/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/30/2017
E815
TEAS SECTION 8 & 15 RECEIVED
11/14/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/13/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/25/2016
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/12/2014
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/12/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
11/13/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/09/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/28/2012
PUBO
PUBLISHED FOR OPPOSITION
08/28/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/08/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/23/2012
ALIE
ASSIGNED TO LIE
07/23/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/14/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/29/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/29/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/29/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/27/2012
GNRT
NON-FINAL ACTION E-MAILED
06/27/2012
CNRT
NON-FINAL ACTION WRITTEN
06/27/2012
DOCK
ASSIGNED TO EXAMINER
06/20/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/14/2012
NWAP
NEW APPLICATION ENTERED
06/08/2012
Continuous trademark protection
Get notified about every new filing that threatens PHARMACEUTICAL STRATEGIES GROUP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.